BRITISH PATIENT CAPITAL
British Patient Capital invests in a diversified portfolio of best-in-class venture and growth capital funds and start ups, capturing value through financing the growth of innovative companies. We invest on a commercial basis to deliver competitive returns and manage risk. As well as providing our own funding we work to encourage more investors to make allocations to this asset class by demonstrating that a long-term patient capital investment strategy can produce commercially attractive returns. Once we’ve established a strong record, and have proved the value of the asset class, we intend to privatise British Patient Capital at an appropriate time in the future.
BRITISH PATIENT CAPITAL
Founded:
2018-03-22
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Nginx Yoast WordPress SEO Plugin Yoast SEO Premium Yoast Plugins COVID-19
Similar Organizations
CDH Investments
CDH Investments is an international alternative asset fund manager with more than $2.0 billion of committed capital under management.
Digital Finance Group (DFG)
Diversified investment group that manages $1B in digital & blockchain assets across multiple funds, an incubator and global projects
IBI Tech Fund
IBI Tech Fund is an Israeli fund investing in early-stage outstanding startups.
Susquehanna Growth Equity
Susquehanna Growth Equity invests in growth stage technology companies in the software, information services, and internet.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-05 | Oxford Quantum Circuits | British Patient Capital investment in Series A - Oxford Quantum Circuits | 38 M GBP |
| 2022-06-21 | CloudNC | British Patient Capital investment in Series B - CloudNC | 45 M USD |
| 2022-06-14 | Proximie | British Patient Capital investment in Series C - Proximie | 80 M USD |
| 2022-03-02 | Epsilogen | British Patient Capital investment in Series B - Epsilogen | 30.75 M GBP |
| 2022-02-07 | Microbiotica | British Patient Capital investment in Series B - Microbiotica | 50 M GBP |
| 2021-11-29 | Thought Machine | British Patient Capital investment in Series C - Thought Machine | 200 M USD |
| 2021-11-29 | Quell Therapeutics | British Patient Capital investment in Series B - Quell Therapeutics | 156 M USD |
| 2021-11-17 | Ultraleap | British Patient Capital investment in Series D - Ultraleap | 60 M GBP |
| 2021-09-15 | Accurx | British Patient Capital investment in Series B - Accurx | 27.5 M GBP |
| 2021-07-13 | Quantexa | British Patient Capital investment in Series D - Quantexa | 153 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-21 | British Patient Capital names Catherine Lewis La Torre as CEO |
| 2021-01-11 | British Patient Capital enters 2021 with a new CEO and £1.5bn to deploy |